Fidelity International’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.9M Sell
597,352
-58,742
-9% -$6.78M 0.06% 287
2025
Q4
$69.1M Sell
656,094
-168,147
-20% -$15.8M 0.05% 286
2025
Q3
$69.2M Buy
824,241
+150,667
+22% +$12.4M 0.05% 288
2025
Q2
$53.3M Buy
673,574
+189,392
+39% +$15.1M 0.05% 328
2025
Q1
$43.5M Buy
484,182
+265,942
+122% +$24.8M 0.04% 333
2024
Q4
$21.7M Sell
218,240
-57,269
-21% -$5.9M 0.02% 430
2024
Q3
$31.3M Sell
275,509
-42,261
-13% -$5.02M 0.03% 404
2024
Q2
$39.3M Sell
317,770
-22,446
-7% -$2.89M 0.04% 362
2024
Q1
$44.9M Buy
340,216
+6,980
+2% +$860K 0.04% 327
2023
Q4
$36.3M Sell
333,236
-76,737
-19% -$7.97M 0.04% 344
2023
Q3
$42.2M Sell
409,973
-25,237
-6% -$2.72M 0.05% 322
2023
Q2
$50.2M Buy
435,210
+360,148
+480% +$40.9M 0.06% 314
2023
Q1
$7.99M Buy
+75,062
New +$8.1M 0.01% 513
2021
Q3
Sell
-142,891
Closed -$11.1M 869
2021
Q2
$11.1M Sell
142,891
-2,438
-2% -$181K 0.01% 539
2021
Q1
$10.7M Buy
145,329
+144,678
+22,224% +$10.7M 0.01% 511
2020
Q4
$51K Sell
651
-160
-20% -$12.2K ﹤0.01% 762
2020
Q3
$65K Buy
811
+50
+7% +$3.92K ﹤0.01% 693
2020
Q2
$56K Sell
761
-302,528
-100% -$22.8M ﹤0.01% 679
2020
Q1
$22.3M Buy
303,289
+29,279
+11% +$2.3M 0.04% 346
2019
Q4
$23.8M Sell
274,010
-613,538
-69% -$50.4M 0.03% 375
2019
Q3
$71.3M Sell
887,548
-3,824,133
-81% -$306M 0.11% 204
2019
Q2
$377M Sell
4,711,681
-1,090,726
-19% -$83.5M 0.57% 38
2019
Q1
$460M Sell
5,802,407
-286,515
-5% -$21.4M 0.72% 28
2018
Q4
$444M Buy
6,088,922
+438,347
+8% +$30.9M 0.79% 26
2018
Q3
$382M Buy
5,650,575
+569,200
+11% +$36.3M 0.57% 35
2018
Q2
$294M Buy
5,081,375
+3,554,963
+233% +$201M 0.44% 48
2018
Q1
$79.3M Sell
1,526,412
-130,866
-8% -$7.07M 0.22% 126
2017
Q4
$89M Sell
1,657,278
-221,872
-12% -$12.3M 0.25% 104
2017
Q3
$115M Buy
1,879,150
+65,937
+4% +$4M 0.33% 88
2017
Q2
$111M Buy
1,813,213
+1,202,583
+197% +$73.2M 0.32% 90
2017
Q1
$37M Buy
610,630
+345,524
+130% +$21M 0.1% 179
2016
Q4
$14.9M Buy
265,106
+39,108
+17% +$2.29M 0.04% 291
2016
Q3
$13.5M Buy
225,998
+17,883
+9% +$1.05M 0.04% 306
2016
Q2
$11.4M Sell
208,115
-45,145
-18% -$2.4M 0.04% 321
2016
Q1
$12.8M Buy
253,260
+19,826
+8% +$971K 0.04% 313
2015
Q4
$11.8M Buy
233,434
+150,575
+182% +$7.59M 0.04% 322
2015
Q3
$3.9M Buy
82,859
+3,370
+4% +$179K 0.01% 401
2015
Q2
$4.32M Sell
79,489
-784
-1% -$44K 0.01% 425
2015
Q1
$4.4M Buy
80,273
+21,216
+36% +$1.2M 0.01% 420
2014
Q4
$3.2M Sell
59,057
-36,106
-38% -$2.01M 0.01% 430
2014
Q3
$5.38M Sell
95,163
-427,769
-82% -$24M 0.02% 394
2014
Q2
$28.9M Sell
522,932
-139,683
-21% -$7.62M 0.11% 193
2014
Q1
$35.9M Sell
662,615
-292,448
-31% -$15.1M 0.13% 170
2013
Q4
$45.6M Sell
955,063
-5,479,418
-85% -$250M 0.18% 138
2013
Q3
$292M Buy
6,434,481
+1,320,525
+26% +$60.3M 1.4% 8
2013
Q2
$227M Buy
+5,113,956
New +$228M 1.28% 11

Other funds holding MRK

Fidelity International's MRK Position: Q1 2026 in Review

Fidelity International reduced its Merck (MRK) stake by 9% in Q1 2026, selling an estimated $6.78M and leaving 597,352 shares worth $71.9M. The position accounts for 0.06% of the portfolio, ranked #287.

Fidelity International first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $460M in Q1 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Fidelity International held 597,352 shares of Merck worth $71.9M as of Q1 2026.
  • Fidelity International sold 58,742 Merck shares in Q1 2026, an estimated $6.78M.
  • Merck made up 0.06% of Fidelity International's portfolio in Q1 2026, its #287 holding.
  • Fidelity International first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
  • Fidelity International's Merck position peaked at $460M in Q1 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.